AUPH - Aurinia drops after Q4 miss; strategic review fails
2024-02-15 07:05:36 ET
More on Aurinia Pharma
- Aurinia Pharmaceuticals: Sales Growth Would Help Buyout Potential
- Aurinia Pharmaceuticals: A Post Q3 Earnings Assessment
- Aurinia Pharma GAAP EPS of -$0.19 misses by $0.03, revenue of $45.1M misses by $0.06M
- Aurinia Pharma Q4 2023 Earnings Preview
- Seeking Alpha’s Quant Rating on Aurinia Pharma